Filip Borgions
Chief Tech/Sci/R&D Officer at ARGENX SE
Profile
Filip Borgions is currently the Global Head-Technical Operations at argenx SE since 2015.
Previously, he worked as a Principal at Thrombogenics, Inc. Dr. Borgions has an undergraduate and doctorate degree from Katholieke Universiteit Leuven.
Filip Borgions active positions
| Companies | Position | Start |
|---|---|---|
| ARGENX SE | Chief Tech/Sci/R&D Officer | 2014-12-31 |
Former positions of Filip Borgions
| Companies | Position | End |
|---|---|---|
Thrombogenics, Inc.
 Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The private company is based in New York, NY. | Corporate Officer/Principal | - |
Training of Filip Borgions
| Katholieke Universiteit Leuven | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ARGENX SE | Health Technology |
| Private companies | 1 |
|---|---|
Thrombogenics, Inc.
Thrombogenics, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Oxurion NV, Thrombogenics, Inc. operates as a biotechnology company that delivers innovative treatments for diseases of the back of the eye, with a focus on diabetic eye disease. The private company is based in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Filip Borgions
